Loading
companiesCompany
F-Prime Capital
F-Prime Capital is the venture firm that grew out of Fidelity's own money. It invests in healthcare and technology companies, including cancer diagnostics and therapeutics, from seed to growth.
Overview
F-Prime Capital is a global venture capital firm with roots in Fidelity Investments, investing in healthcare, life sciences and technology companies from company formation to growth stage, with offices in Cambridge (Massachusetts), San Francisco and London. Its healthcare portfolio spans therapeutics, diagnostics, medical devices and health IT, and includes oncology companies at several stages. Portfolio links in OnCo are derived from the startup records that name it.
Portfolio (2)
Filter the startups table| Company | Stage | Type | Cancers | Latest round |
|---|---|---|---|---|
| Adela Toronto, CA | Startup | diagnostics | Series A 2023, $48M | |
| K36 Therapeutics Cambridge, MA, US | Startup | biotech | Multiple myelomaProstate cancer | Series B 2023, $70M |
Similar pages
- CompanyDeerfield Management
Shares Adela and the tag vc.
- CompanyOrbiMed
Shares Adela and the tag vc.
- CompanyAtlas Venture
Shares K36 Therapeutics and the tag vc.
- CompanyRA Capital Management
Shares Adela and the tag vc.